Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sanofi crawled date : 2021 - 06 - 28 save search
Pharma, Research, And Medical Leaders Say Kidney Patients Are Key To Care Innovation
Published: 2021-06-28 (Crawled : 20:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.03%
H: 0.28%
C: 0.08%
CDNA | $8.21 0.49% 0.49% 450K
|
Health Technology
|
| O: 0.18%
H: 1.68%
C: -0.61%
ARDX | $6.38 -2.0% -2.04% 3.8M
|
Health Technology
|
| O: 0.5%
H: 0.31%
C: -1.88%
AKBA | $1.365 0.37% 0.37% 2.1M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: -5.65%
research kidney pharma
AstraZeneca, Sanofi’s Monoclonal RSV Antibody Shows Promising Safety in Infants
Published: 2021-06-28 (Crawled : 19:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
antibody
New Soliqua data shows improved blood sugar control without weight gain versus premixed insulin
Published: 2021-06-28 (Crawled : 18:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
blood insulin
Clinical Catch-Up: June 21-25
Published: 2021-06-28 (Crawled : 17:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.7%
H: 0.48%
C: -3.58%
AVXL | $3.68 0.0% 1.4M
|
Health Technology
|
| O: 20.0%
H: 6.06%
C: -2.83%
The American Diabetes Association and Partners Commemorate 100th Anniversary of Discovery of Insulin and Look to the Next 100 Years for Breakthroughs Ahead
Published: 2021-06-28 (Crawled : 17:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
diabetes insulin
New Soliqua 100/33 data shows improved blood sugar control without weight gain versus premixed insulin
Published: 2021-06-28 (Crawled : 14:15) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
blood insulin
Lengo Therapeutics Appoints Enoch K. Kariuki as Chief Executive Officer
Published: 2021-06-28 (Crawled : 13:00) - biospace.com/
ZNTL | $12.58 -3.23% -3.34% 380K
|
Health Technology
|
| O: 0.1%
H: 2.45%
C: -4.89%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
therapeutics
Atsena Therapeutics Receives Orphan Drug Designation from the FDA for Novel Gene Therapy to Treat Genetic Eye Disease LCA1Phase I/II clinical trial is ongoing in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D
Published: 2021-06-28 (Crawled : 13:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
disease fda genetic ongoing eye gene therapy therapy eye disease drug trial gene therapies designation
Denali Therapeutics Announces Initiation of Phase 2 Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in Cutaneous Lupus Erythematosus (CLE) Patients
Published: 2021-06-28 (Crawled : 12:15) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 1.23%
H: 1.19%
C: -0.73%
phase 2 lupus
US Patient Perspective Survey of the Corporate Reputation of Pharma in 2020: Opinions of 207 US-based Patient Groups on the Performance of the Pharmaceutical Industry
Published: 2021-06-28 (Crawled : 11:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.14%
H: 0.38%
C: -0.26%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
Kymera Therapeutics Announces Positive Interim Results from Single Ascending Dose Phase 1 Trial of KT-474 Demonstrating Degrader Proof-of-Mechanism
Published: 2021-06-28 (Crawled : 10:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
KYMR | $35.7 3.93% 3.78% 440K
|
Health Technology
|
| O: 2.97%
H: 3.46%
C: 3.24%
phase 1 positive results trial phase 2
Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial
Published: 2021-06-28 (Crawled : 08:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
phase 2 phase 2/3 positive results topline trial
Dupixent® (dupilumab) SmPC Updated with Long-term Data Reinforcing Well-established Safety Profile in Adults with Moderate-to-severe Atopic Dermatitis
Published: 2021-06-28 (Crawled : 05:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.47%
C: 0.24%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: 2.72%
H: 0.79%
C: -4.04%
dermatitis atopic dermatitis dupixent
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.